Literature DB >> 3300535

Liposomes as carriers of antimicrobial agents.

G Lopez-Berestein.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3300535      PMCID： PMC174813          DOI： 10.1128/AAC.31.5.675

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  41 in total

1.  Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages.

Authors:  I A Bakker-Woudenberg; A F Lokerse; J C Vink-van den Berg; F H Roerdink; M F Michel
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

2.  Antileishmanial activity of antimonials entrapped in liposomes.

Authors:  R R New; M L Chance; S C Thomas; W Peters
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

3.  The structure and function of amphotericin B-cholesterol pores in lipid bilayer membranes.

Authors:  T E Andreoli
Journal:  Ann N Y Acad Sci       Date:  1974-05-10       Impact factor: 5.691

4.  Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug.

Authors:  C R Alving; E A Steck; W L Hanson; P S Loizeaux; W L Chapman; V B Waits
Journal:  Life Sci       Date:  1978-03       Impact factor: 5.037

5.  Primaquine liposomes in the chemotherapy of experimental murine malaria.

Authors:  P Pirson; R F Steiger; A Trouet; J Gillet; F Herman
Journal:  Ann Trop Med Parasitol       Date:  1980-08

6.  Killing of intraphagocytic Staphylococcus aureus by dihydrostreptomycin entrapped within liposomes.

Authors:  P F Bonventre; G Gregoriandis
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

7.  [Liposomes as vehicles of antitubercular drugs - a new appraoch to experimental chemotherapy of tuberculosis].

Authors:  M A Vladimirskiĭ; V P Strel'tsov; V M Stapanov; V I Braude
Journal:  Probl Tuberk       Date:  1980-07

8.  Liposomes in leishmaniasis: therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline.

Authors:  C R Alving; E A Steck; W L Chapman; V B Waits; L D Hendricks; G M Swartz; W L Hanson
Journal:  Life Sci       Date:  1980-06-30       Impact factor: 5.037

9.  Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

Authors:  G Lopez-Berestein; G P Bodey; L S Frankel; K Mehta
Journal:  J Clin Oncol       Date:  1987-02       Impact factor: 44.544

10.  Preparation and properties of liposome-associated gentamicin.

Authors:  J R Morgan; K E Williams
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191
View more
  20 in total

1.  Lyophilized lecithin based oil-water microemulsions as a new and low toxic delivery system for amphotericin B.

Authors:  M A Moreno; P Frutos; M P Ballesteros
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

2.  Cellular retention of liposome-delivered anionic compounds modulated by a probenecid-sensitive anion transporter.

Authors:  Y K Oh; R M Straubinger
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

Review 3.  High-resolution CT vascular imaging using blood pool contrast agents.

Authors:  Ananth V Annapragada; Eric Hoffman; Abhay Divekar; Efstathios Karathanasis; Ketan B Ghaghada
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

4.  Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.

Authors:  V Heinemann; D Bosse; U Jehn; B Kähny; K Wachholz; A Debus; P Scholz; H J Kolb; W Wilmanns
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

5.  Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue.

Authors:  Siqin Zhaorigetu; Cristian Rodriguez-Aguayo; Anil K Sood; Gabriel Lopez-Berestein; Brian L Walton
Journal:  J Liposome Res       Date:  2014-01-20       Impact factor: 3.648

Review 6.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

7.  Liposomal amphotericin B therapy of murine histoplasmosis.

Authors:  J R Graybill; R Bocanegra
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

8.  Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salmonellosis.

Authors:  E Fattal; J Rojas; M Youssef; P Couvreur; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

9.  Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension.

Authors:  Vivek Gupta; Nilesh Gupta; Imam H Shaik; Reza Mehvar; Ivan F McMurtry; Masahiko Oka; Eva Nozik-Grayck; Masanobu Komatsu; Fakhrul Ahsan
Journal:  J Control Release       Date:  2013-01-23       Impact factor: 9.776

10.  Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice.

Authors:  H Saito; H Tomioka
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.